Belantamab (FUT-8 KO)

Product Description: Belantamab (FUT-8 KO) is an anti-BCMA (TNFRSF17) monoclonal antibody expressed by CHO cells with the fucosyltransferase 8 gene (FUT8) knocked out. Fucose deficiency enhances the ADCC effect of the antibody. Belantamab (FUT-8 KO) can be used to synthesize antibody-active molecule conjugate (ADC), Belantamab mafodotin[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ivo Demel, et al. Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021. Br J Haematol. 2021 May;193(4):705-722.

Molecular Weight: N/A

Research Area: Cancer

Target: ADC Antibody;TNF Receptor

• Artikelnummer: MEXHY-P9980A-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9980A-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated